Nexalin Cost Of Revenue vs Reconciled Depreciation Analysis

NXLIW Stock

USD 0.62 0.21 51.22%

Nexalin Technology financial indicator trend analysis is infinitely more than just investigating Nexalin Technology recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nexalin Technology is a good investment. Please check the relationship between Nexalin Technology Cost Of Revenue and its Reconciled Depreciation accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Nexalin Stock please use our How to Invest in Nexalin Technology guide.

Cost Of Revenue vs Reconciled Depreciation

Cost Of Revenue vs Reconciled Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nexalin Technology Cost Of Revenue account and Reconciled Depreciation. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Nexalin Technology's Cost Of Revenue and Reconciled Depreciation is -0.61. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Reconciled Depreciation in the same time period over historical financial statements of Nexalin Technology, assuming nothing else is changed. The correlation between historical values of Nexalin Technology's Cost Of Revenue and Reconciled Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Nexalin Technology are associated (or correlated) with its Reconciled Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Reconciled Depreciation has no effect on the direction of Cost Of Revenue i.e., Nexalin Technology's Cost Of Revenue and Reconciled Depreciation go up and down completely randomly.

Correlation Coefficient

-0.61

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Nexalin Technology income statement and represents the costs associated with goods and services Nexalin Technology provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Reconciled Depreciation

Most indicators from Nexalin Technology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nexalin Technology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Nexalin Stock please use our How to Invest in Nexalin Technology guide.Sales General And Administrative To Revenue is likely to climb to 54.81 in 2024, whereas Selling General Administrative is likely to drop slightly above 4 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	82.3K	59.4K	38.8K	54.4K
Depreciation And Amortization	537.0	5.7K	4.3K	2.5K

Interest Expense Depreciation And Amortization

Nexalin Technology fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Long Term Debt	Capital Lease Obligations	Net Invested Capital
Total Assets		-0.47	0.37	0.16	0.95	0.72	-0.48	-0.71	0.23	0.38	0.43	0.37	1.0	0.07	0.26	-0.8	0.93	0.84	0.86	-0.01	1.0	-0.22	0.9	-0.79	-0.74	0.99
Short Long Term Debt Total	-0.47		-0.04	0.55	-0.67	0.24	0.94	0.86	0.46	-0.59	-0.99	-0.99	-0.43	-0.32	-0.75	0.74	-0.69	-0.86	-0.79	0.71	-0.45	0.95	-0.71	0.62	0.91	-0.56
Other Current Liab	0.37	-0.04		0.8	0.19	0.28	-0.31	-0.47	0.85	0.67	0.0	-0.02	0.38	0.76	-0.01	-0.63	0.28	0.21	0.48	0.67	0.37	0.25	0.49	-0.66	-0.3	0.29
Total Current Liabilities	0.16	0.55	0.8		-0.12	0.52	0.31	0.08	0.99	0.17	-0.59	-0.61	0.19	0.36	-0.45	-0.13	-0.07	-0.26	-0.01	0.98	0.17	0.78	0.06	-0.23	0.24	0.04
Total Stockholder Equity	0.95	-0.67	0.19	-0.12		0.54	-0.63	-0.8	-0.04	0.38	0.65	0.6	0.94	0.05	0.49	-0.82	0.95	0.95	0.9	-0.3	0.95	-0.49	0.91	-0.76	-0.86	0.98
Property Plant And Equipment Net	0.72	0.24	0.28	0.52	0.54		0.25	-0.09	0.5	-0.17	-0.29	-0.35	0.76	-0.31	-0.23	-0.28	0.47	0.25	0.29	0.47	0.74	0.45	0.39	-0.28	-0.08	0.66
Net Debt	-0.48	0.94	-0.31	0.31	-0.63	0.25		0.93	0.19	-0.81	-0.95	-0.94	-0.44	-0.61	-0.7	0.84	-0.68	-0.84	-0.85	0.49	-0.46	0.83	-0.77	0.79	0.94	-0.54
Retained Earnings	-0.71	0.86	-0.47	0.08	-0.8	-0.09	0.93		-0.03	-0.77	-0.85	-0.82	-0.69	-0.56	-0.7	0.96	-0.8	-0.93	-0.96	0.29	-0.7	0.66	-0.9	0.9	0.97	-0.74
Accounts Payable	0.23	0.46	0.85	0.99	-0.04	0.5	0.19	-0.03		0.3	-0.49	-0.51	0.26	0.46	-0.37	-0.23	0.01	-0.16	0.1	0.94	0.24	0.71	0.16	-0.35	0.12	0.11
Cash	0.38	-0.59	0.67	0.17	0.38	-0.17	-0.81	-0.77	0.3		0.6	0.59	0.35	0.9	0.3	-0.76	0.54	0.57	0.73	0.01	0.37	-0.4	0.7	-0.87	-0.72	0.38
Non Current Assets Total	0.43	-0.99	0.0	-0.59	0.65	-0.29	-0.95	-0.85	-0.49	0.6		1.0	0.39	0.34	0.77	-0.7	0.65	0.85	0.77	-0.74	0.41	-0.96	0.68	-0.61	-0.9	0.52
Non Currrent Assets Other	0.37	-0.99	-0.02	-0.61	0.6	-0.35	-0.94	-0.82	-0.51	0.59	1.0		0.33	0.35	0.77	-0.67	0.61	0.82	0.73	-0.75	0.36	-0.97	0.64	-0.58	-0.88	0.47
Cash And Short Term Investments	1.0	-0.43	0.38	0.19	0.94	0.76	-0.44	-0.69	0.26	0.35	0.39	0.33		0.06	0.25	-0.79	0.91	0.81	0.83	0.03	1.0	-0.18	0.88	-0.77	-0.71	0.99
Net Receivables	0.07	-0.32	0.76	0.36	0.05	-0.31	-0.61	-0.56	0.46	0.9	0.34	0.35	0.06		0.26	-0.55	0.16	0.25	0.45	0.24	0.07	-0.16	0.39	-0.66	-0.44	0.05
Common Stock Shares Outstanding	0.26	-0.75	-0.01	-0.45	0.49	-0.23	-0.7	-0.7	-0.37	0.3	0.77	0.77	0.25	0.26		-0.53	0.31	0.65	0.52	-0.56	0.25	-0.72	0.38	-0.37	-0.68	0.32
Non Current Liabilities Total	-0.8	0.74	-0.63	-0.13	-0.82	-0.28	0.84	0.96	-0.23	-0.76	-0.7	-0.67	-0.79	-0.55	-0.53		-0.85	-0.89	-0.98	0.08	-0.8	0.49	-0.95	0.94	0.92	-0.81
Inventory	0.93	-0.69	0.28	-0.07	0.95	0.47	-0.68	-0.8	0.01	0.54	0.65	0.61	0.91	0.16	0.31	-0.85		0.92	0.93	-0.25	0.93	-0.49	0.97	-0.84	-0.87	0.96
Other Current Assets	0.84	-0.86	0.21	-0.26	0.95	0.25	-0.84	-0.93	-0.16	0.57	0.85	0.82	0.81	0.25	0.65	-0.89	0.92		0.95	-0.45	0.83	-0.7	0.92	-0.82	-0.97	0.88
Other Stockholder Equity	0.86	-0.79	0.48	-0.01	0.9	0.29	-0.85	-0.96	0.1	0.73	0.77	0.73	0.83	0.45	0.52	-0.98	0.93	0.95		-0.22	0.85	-0.57	0.99	-0.94	-0.96	0.88
Total Liab	-0.01	0.71	0.67	0.98	-0.3	0.47	0.49	0.29	0.94	0.01	-0.74	-0.75	0.03	0.24	-0.56	0.08	-0.25	-0.45	-0.22		0.0	0.89	-0.14	-0.03	0.44	-0.13
Total Current Assets	1.0	-0.45	0.37	0.17	0.95	0.74	-0.46	-0.7	0.24	0.37	0.41	0.36	1.0	0.07	0.25	-0.8	0.93	0.83	0.85	0.0		-0.21	0.9	-0.78	-0.73	0.99
Short Term Debt	-0.22	0.95	0.25	0.78	-0.49	0.45	0.83	0.66	0.71	-0.4	-0.96	-0.97	-0.18	-0.16	-0.72	0.49	-0.49	-0.7	-0.57	0.89	-0.21		-0.47	0.36	0.75	-0.33
Common Stock	0.9	-0.71	0.49	0.06	0.91	0.39	-0.77	-0.9	0.16	0.7	0.68	0.64	0.88	0.39	0.38	-0.95	0.97	0.92	0.99	-0.14	0.9	-0.47		-0.94	-0.92	0.92
Long Term Debt	-0.79	0.62	-0.66	-0.23	-0.76	-0.28	0.79	0.9	-0.35	-0.87	-0.61	-0.58	-0.77	-0.66	-0.37	0.94	-0.84	-0.82	-0.94	-0.03	-0.78	0.36	-0.94		0.87	-0.78
Capital Lease Obligations	-0.74	0.91	-0.3	0.24	-0.86	-0.08	0.94	0.97	0.12	-0.72	-0.9	-0.88	-0.71	-0.44	-0.68	0.92	-0.87	-0.97	-0.96	0.44	-0.73	0.75	-0.92	0.87		-0.79
Net Invested Capital	0.99	-0.56	0.29	0.04	0.98	0.66	-0.54	-0.74	0.11	0.38	0.52	0.47	0.99	0.05	0.32	-0.81	0.96	0.88	0.88	-0.13	0.99	-0.33	0.92	-0.78	-0.79

Click cells to compare fundamentals

Nexalin Technology Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Nexalin Stock Analysis

When running Nexalin Technology's price analysis, check to measure Nexalin Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nexalin Technology is operating at the current time. Most of Nexalin Technology's value examination focuses on studying past and present price action to predict the probability of Nexalin Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nexalin Technology's price. Additionally, you may evaluate how the addition of Nexalin Technology to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nexalin Cost Of Revenue vs Reconciled Depreciation Analysis

Cost Of Revenue vs Reconciled Depreciation

Cost Of Revenue vs Reconciled Depreciation Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Reconciled Depreciation

Nexalin Technology fundamental ratios Correlations

Nexalin Technology Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Nexalin Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Non Currrent Assets Other	+ 1.0	Non Current Assets Total
Total Current Assets	+ 1.0	Cash And Short Term Investments
Net Invested Capital	+ 0.99	Total Assets
Accounts Payable	+ 0.99	Total Current Liabilities

Non Currrent Assets Other	- 0.99	Short Long Term Debt Total
Non Current Assets Total	- 0.99	Short Long Term Debt Total
Other Stockholder Equity	- 0.98	Non Current Liabilities Total
Capital Lease Obligations	- 0.97	Other Current Assets
Short Term Debt	- 0.97	Non Currrent Assets Other
Capital Lease Obligations	- 0.96	Other Stockholder Equity